pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-127 |
Genomic Coordinates | chr14: 100882979 - 100883075 |
Description | Homo sapiens miR-127 stem-loop |
Comment | This miRNA sequence is predicted based on homology to a verified miRNA from mouse . |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | |||||||
---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-127-5p | ||||||
Sequence | 23| CUGAAGCUCAGAGGGCUCUGAU |44 | ||||||
Evidence | Experimental | ||||||
Experiments | Cloned | DRVs in miRNA |
|
||||
SNPs in miRNA |
|
||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | USP22 | ||||||||||||||||||||
Synonyms | USP3L | ||||||||||||||||||||
Description | ubiquitin specific peptidase 22 | ||||||||||||||||||||
Transcript | NM_015276 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on USP22 | |||||||||||||||||||||
3'UTR of USP22 (miRNA target sites are highlighted) |
>USP22|NM_015276|3'UTR 1 CCTTATCTGCAGCTGGTCAGAAAAACAAAGGCAATGCATTGGCAAGCCTCACAAAGTGATCCTCCCTGGCCCCCCCCTCC 81 CCCAAGTCTCCCGCCGCCTCCCCGGCCTGGTGACACCACCTCCCATGCAGATGTGGCCCCTCTGCACCTGGGACCCATCG 161 GGTCGGGATGGACCACACGGACGGGGAGGCTCCTGGAGCTGCTTTGAAGATGGATGAGATGAGGGGTGTGCTCTGGGTGG 241 GAGGAGCAGCGTACACCCGTCACCAGAACATCTCTTGTGTCATGACATGGGGGTGCAACGGGGGCCTCACAGCACAGAGT 321 GACCGCTGCCTGGCGTTCCCCAGCACTCGGTGTGGAAAGGCCCCTACCTGCTGTAAGATTATGGGTCCATGAAAGCAGTA 401 AGCTGGACACAGAGGTGTAGTGTGCGGGACAGAGGGCCTTGCAGATGCCTTTCTGTTGGTGTTTTAGTGTTAAAATACGG 481 AGAGTATGGAACTCTTCACCTCCATTTTCTCAGCGGCTGTGAAGCAGCCTCCTAGCTTCGGAAGTACGGACACTACGTCG 561 CGTTTTCAAGCGTGTCTGTTCTGCAGGTAACAGCATCAAGCTGCACGTGGAAGCATCTCGCGGTTTTCTAGAAACAGGCA 641 TTTTCTTATCCCTCTCCCGCTCCTTTTTCCACAAAGGTGAATTTCATAAATGTAATACTAGTAAAGTGAATGAATTACTG 721 AGTTTATACAGAAATTTAGGTAACTTCTCCTTTAGTCTCAAGAGCGAGTCTTGCTTTTTAATGGGTGCCGTTTATGTTGC 801 TGCCCGCCCTGTGTGCCTGGCTCCTCTGGGTGCCTTGGTGTCTGCTGGTGGCTGGCAGTGGGCGCAGCGGAGGAGAGTTG 881 TGCTGCAGCTCATACGGTGTGTCTGTCATCTCAGTCTGGAGTAAATGCAGTGTCTGCCGGTGTCTGATGGGTTCTGTCCC 961 TCGTATTTTCTTTGCCTTCTATCCCATTGCCTGGCTACCGCTGCCTGGCAGCCAAGGGTGTTGGTCGCGAAGCTGGAGTG 1041 GCCTCTGGTGGAGCCTGCATCTTGTCTCGTCTGCCTCTGCTTTACATTTGGTGTACTTTCGGGCGTGGTGGCAGTAAAAT 1121 GACACCGTGATTGAGCTTGTCAGCAGAGCTGAAAGAGAAAGTAGAAGGATGTGCATTGTTTCTTGTAAGATATCTTGCAT 1201 GTATCTGTGTATTCAAATTCAAACAGAGATGGTTTGTCCATTTGTCCACTGAGAAATTAGAAACTAGGGACAAGGGGGAG 1281 GAAAAGTACTGAAATACAGTTTATGAAGCAAGTGTGTCTCGGGCTGTGCTTGTCCCAGGAGCCCCAGCAGCATCTGAACT 1361 GAGGCTTCTTCAGTCCTGCAGGAACAGGATCATCTGTCTCAGCGGTGGGCAGATGTTTTCATAGACAGCCAGGGAGTAAA 1441 CACTGTTGGCTCTGTGGGCTGTATGGTCTCTGCCATAAATAGTACAGAGATGTGGCTGTGTCTAGTACAACTTTTAGACA 1521 CAGAAATCTGAATGACATATATTGTTCTGTGTCAAGAAACTTAGATTTTTTTTTTAACTATTTAAAAACGTGAAACCTAT 1601 TCTTAGCTCACAGGCCATGGAGAAGCTGGTGGGGACCAGACCCAGCTCCTTAGCTGGCTGGGCTGGGGAGGGGGTAGTGA 1681 CAGTGGCAGCTGCTACTCACTGCTCAGTGTGGAAAACACAGGACTTGGCAATCACAGCCCGCAGAACCATCATGTGTGGC 1761 AGAAGCCTGAGGGATGCGGTTTCTTGCCCACGTGCTCTGTTCATTTTCTGTTGTTTTTCTGCACTTAAAGAATTCACATG 1841 GAAGCATGTTTTATAAAATGAATTACCAGAGAAACAGAGATGGGCCGAGATTTTCAGAAATGGTCCCATGTGACCAAGTT 1921 CTGCTGTTTGGGTGACAGTGCTTTGAAGATCTCCTTTGAGGATGTGCAGTCTTTTTTTTTTTTTTTTTGAGATGGAGTTT 2001 GTTGCCCAGGCTGGAGTGAGTGGCACAGTCTCGGCTCACTGCAACCTCCACCTCCTGGGTTCAAGCAGTTCTCGTGCCGC 2081 AGCCTCCCAAGTAGCTGGGACTACAGGCATGCACCACCACGCCAGGCTAATTTTTGTATTTTTAGTAGAGATGGGGTTTC 2161 ACCATGTCTCAAACTCCTGACCTCAGGCGATCCACCCACCTCAGCGTCCCAAAGTGCTGGGATTATAGGCGTGAGCCACC 2241 GCACCTGGCCTATGAGTGGTCTTTTAATTAGGAACAAATCTAATGGAAAGGAGAGTTGACTGAAGTTGGCCCACAGGATT 2321 GTGAGCTGGGCAGTGCCTTCATGAAGGCTTGCCACCTTGGGACGCCCCAGTTTACTGGGGTGTCTTGCGGAGTGCAGAAG 2401 GCTTTCTGGCAGCTGCCTGGGTTTGGCCAGACCCTGCCTCCCCTCCCGCCGGCCAACCCCTAGTCCCCTTCCTGTCTCCA 2481 CTTGCATTCAGGGGTGGCTGCTGTTCTGAGAACATTAGAACTGGGAAGAGAGATGGAGTCACATGGATTTTTGGTGGGCA 2561 TTATTCTAAACTTTCGTATCCAAGTTAGTCCCCCTTATTCCACTGTGGCATTGCCGTTCTAAGCAGTTACCTGATGCCTG 2641 CTGCTGAAGAGCTGCTCACAGGAGGCGGCGGCGGCCCTGGCACTGCCCCTTGCATTAGGTCTTGTGTTTGATGTGTTCTT 2721 GTGAATTTACTTTGTCAGAACAAAATATTTACGCGTTGGGTTCAGGAATTTCTTTTAGCTCCCCATCTGGCTGTGAAATT 2801 CAGGAAACCTCCCGTTGCCTAGTAATCACCCCATGTAGGTGTACATTGTGACAAAGTGCATCTGACCACTAAGGGGCCCC 2881 CTTGGTGACCCCAGCACATTCACAGCAGTGTTAAAATGGCCTGCATTTTGGAGATGCTGGCTGGCCTTTCAGTGCCTCCC 2961 AGGAAGACACATGGCCTTTCCCTCTTCAGATGCCTGAAGGGAGTGCTTTGAGGCAGGTGATGTGCTGGGAGTGTGGGCGG 3041 CCTCCCTCTGGCCCCGGGGCCCTCTGTGGACCTTGGCTCCCTCCGTGGACCTGGGCTTCGTGGTGAGCACTGCAGCCTCC 3121 CTGGGCATTCCCTCCAGCGCCAGCACCACTGCAACATATAGACCTGAGTGCTATTGTATTTTGGCTTGGTGTGTATGCTC 3201 TTCATTGTGTAAAATTGCTGTTCTTTTGACAATTTAAGTGATTGTTTTGTTTACTGTAAGTTTGAAAATAAAAATGAAGA 3281 AAAAAATTCCAATGACTGTGCTGTGGTTGGAGACTTTATTTACCAAGATGTTTACTCTTCCTTTCCCCTTCCATTTTGAG 3361 GAGCTGTGTCACTCCTCCTCCCCCCCAGTGCTTTGTAGTCTCTCCTATGTCATAATAAAGCTACATTTTCTCTGAGAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | islets |
Tools used in this research | TargetScan |
Original Description (Extracted from the article) |
...
HITS-CLIP data was present in Supplenentary. RNA binding protein: AGO.
... - Kameswaran V; Bramswig NC; McKenna LB; Penn et al., 2014, Cell metabolism. |
Article |
- Kameswaran V; Bramswig NC; McKenna LB; Penn et al. - Cell metabolism, 2014
Type 2 diabetes mellitus (T2DM) is a complex disease characterized by the inability of the insulin-producing beta cells in the endocrine pancreas to overcome insulin resistance in peripheral tissues. To determine if microRNAs are involved in the pathogenesis of human T2DM, we sequenced the small RNAs of human islets from diabetic and nondiabetic organ donors. We identified a cluster of microRNAs in an imprinted locus on human chromosome 14q32 that is highly and specifically expressed in human beta cells and dramatically downregulated in islets from T2DM organ donors. The downregulation of this locus strongly correlates with hypermethylation of its promoter. Using HITS-CLIP for the essential RISC-component Argonaute, we identified disease-relevant targets of the chromosome 14q32 microRNAs, such as IAPP and TP53INP1, that cause increased beta cell apoptosis upon overexpression in human islets. Our results support a role for microRNAs and their epigenetic control by DNA methylation in the pathogenesis of T2DM.
LinkOut: [PMID: 24374217]
|
MiRNA-Target Expression Profile | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
113 hsa-miR-127-5p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT380928 | ZNF264 | zinc finger protein 264 | 2 | 2 | ||||||||
MIRT439324 | USP34 | ubiquitin specific peptidase 34 | 1 | 1 | ||||||||
MIRT439333 | USP22 | ubiquitin specific peptidase 22 | 1 | 1 | ||||||||
MIRT439379 | TTC37 | tetratricopeptide repeat domain 37 | 1 | 1 | ||||||||
MIRT439445 | TMEM116 | transmembrane protein 116 | 1 | 1 | ||||||||
MIRT439498 | SYNJ2 | synaptojanin 2 | 1 | 1 | ||||||||
MIRT439525 | STBD1 | starch binding domain 1 | 1 | 1 | ||||||||
MIRT439562 | SORL1 | sortilin related receptor 1 | 1 | 1 | ||||||||
MIRT439660 | SF3B1 | splicing factor 3b subunit 1 | 1 | 1 | ||||||||
MIRT439749 | ROGDI | rogdi homolog | 1 | 1 | ||||||||
MIRT439836 | RAB3B | RAB3B, member RAS oncogene family | 1 | 1 | ||||||||
MIRT439923 | PPL | periplakin | 1 | 1 | ||||||||
MIRT439963 | PKD1 | polycystin 1, transient receptor potential channel interacting | 1 | 1 | ||||||||
MIRT439985 | PHKG2 | phosphorylase kinase catalytic subunit gamma 2 | 1 | 1 | ||||||||
MIRT440029 | PCLO | piccolo presynaptic cytomatrix protein | 1 | 1 | ||||||||
MIRT440179 | MTRNR2L8 | MT-RNR2-like 8 | 1 | 1 | ||||||||
MIRT440183 | MTRNR2L4 | MT-RNR2-like 4 | 1 | 1 | ||||||||
MIRT440184 | MTRNR2L6 | MT-RNR2-like 6 | 1 | 1 | ||||||||
MIRT440194 | MTRNR2L1 | MT-RNR2-like 1 | 1 | 1 | ||||||||
MIRT440269 | MBP | myelin basic protein | 1 | 1 | ||||||||
MIRT440323 | LIN7C | lin-7 homolog C, crumbs cell polarity complex component | 1 | 1 | ||||||||
MIRT440331 | LGALS8 | galectin 8 | 1 | 1 | ||||||||
MIRT440355 | KLHL29 | kelch like family member 29 | 1 | 1 | ||||||||
MIRT440397 | KDM6B | lysine demethylase 6B | 1 | 1 | ||||||||
MIRT440411 | KAT2B | lysine acetyltransferase 2B | 1 | 1 | ||||||||
MIRT440424 | ITCH | itchy E3 ubiquitin protein ligase | 1 | 1 | ||||||||
MIRT440651 | FBXO7 | F-box protein 7 | 1 | 1 | ||||||||
MIRT440773 | DST | dystonin | 1 | 1 | ||||||||
MIRT440824 | DGKD | diacylglycerol kinase delta | 1 | 1 | ||||||||
MIRT440914 | COPA | coatomer protein complex subunit alpha | 1 | 1 | ||||||||
MIRT441118 | BBS4 | Bardet-Biedl syndrome 4 | 1 | 1 | ||||||||
MIRT441153 | ATP2A3 | ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3 | 1 | 1 | ||||||||
MIRT441193 | ARID1A | AT-rich interaction domain 1A | 1 | 1 | ||||||||
MIRT441260 | ADM | adrenomedullin | 1 | 1 | ||||||||
MIRT441282 | ACTB | actin beta | 1 | 1 | ||||||||
MIRT441306 | ABHD2 | abhydrolase domain containing 2 | 1 | 1 | ||||||||
MIRT441860 | TEX35 | testis expressed 35 | 2 | 2 | ||||||||
MIRT442190 | CCDC132 | VPS50, EARP/GARPII complex subunit | 2 | 2 | ||||||||
MIRT442886 | RHCG | Rh family C glycoprotein | 2 | 2 | ||||||||
MIRT444158 | ZNF701 | zinc finger protein 701 | 2 | 2 | ||||||||
MIRT444506 | ZNF525 | zinc finger protein 525 | 2 | 2 | ||||||||
MIRT444770 | NAPEPLD | N-acyl phosphatidylethanolamine phospholipase D | 2 | 2 | ||||||||
MIRT445830 | SRSF11 | serine and arginine rich splicing factor 11 | 2 | 2 | ||||||||
MIRT445850 | LRRC1 | leucine rich repeat containing 1 | 2 | 2 | ||||||||
MIRT445863 | ENTPD7 | ectonucleoside triphosphate diphosphohydrolase 7 | 2 | 2 | ||||||||
MIRT446161 | C8A | complement C8 alpha chain | 2 | 2 | ||||||||
MIRT447117 | SLFN5 | schlafen family member 5 | 2 | 2 | ||||||||
MIRT447990 | CDX1 | caudal type homeobox 1 | 2 | 2 | ||||||||
MIRT449032 | ADAMTS5 | ADAM metallopeptidase with thrombospondin type 1 motif 5 | 2 | 2 | ||||||||
MIRT449295 | SMIM19 | small integral membrane protein 19 | 2 | 2 | ||||||||
MIRT449541 | PCDH9 | protocadherin 9 | 2 | 2 | ||||||||
MIRT449579 | ZNF510 | zinc finger protein 510 | 2 | 2 | ||||||||
MIRT450062 | SYT9 | synaptotagmin 9 | 2 | 2 | ||||||||
MIRT450437 | CAPZA1 | capping actin protein of muscle Z-line alpha subunit 1 | 2 | 2 | ||||||||
MIRT450449 | ZDHHC2 | zinc finger DHHC-type containing 2 | 2 | 2 | ||||||||
MIRT450695 | RORA | RAR related orphan receptor A | 2 | 2 | ||||||||
MIRT453654 | RAB6C | RAB6C, member RAS oncogene family | 2 | 2 | ||||||||
MIRT463771 | YOD1 | YOD1 deubiquitinase | 2 | 2 | ||||||||
MIRT468425 | SETD1B | SET domain containing 1B | 2 | 2 | ||||||||
MIRT468843 | RRM2 | ribonucleotide reductase regulatory subunit M2 | 2 | 2 | ||||||||
MIRT475594 | HMGB2 | high mobility group box 2 | 4 | 4 | ||||||||
MIRT478284 | DDX19A | DEAD-box helicase 19A | 2 | 2 | ||||||||
MIRT487594 | NKD2 | naked cuticle homolog 2 | 2 | 4 | ||||||||
MIRT493440 | KANSL1 | KAT8 regulatory NSL complex subunit 1 | 2 | 6 | ||||||||
MIRT496169 | RPL35A | ribosomal protein L35a | 2 | 4 | ||||||||
MIRT497566 | CCR6 | C-C motif chemokine receptor 6 | 2 | 2 | ||||||||
MIRT497917 | BTG1 | BTG anti-proliferation factor 1 | 2 | 2 | ||||||||
MIRT498331 | PRELID2 | PRELI domain containing 2 | 2 | 2 | ||||||||
MIRT498369 | KLHL11 | kelch like family member 11 | 2 | 2 | ||||||||
MIRT498856 | LITAF | lipopolysaccharide induced TNF factor | 2 | 2 | ||||||||
MIRT505640 | SHOC2 | SHOC2, leucine rich repeat scaffold protein | 2 | 2 | ||||||||
MIRT506128 | PLRG1 | pleiotropic regulator 1 | 2 | 4 | ||||||||
MIRT512242 | ARPP19 | cAMP regulated phosphoprotein 19 | 2 | 4 | ||||||||
MIRT512489 | ARID2 | AT-rich interaction domain 2 | 2 | 2 | ||||||||
MIRT525251 | RNF213 | ring finger protein 213 | 2 | 2 | ||||||||
MIRT530197 | ALX1 | ALX homeobox 1 | 2 | 4 | ||||||||
MIRT530551 | NKIRAS2 | NFKB inhibitor interacting Ras like 2 | 2 | 2 | ||||||||
MIRT534048 | STC2 | stanniocalcin 2 | 2 | 2 | ||||||||
MIRT537508 | FAM105A | family with sequence similarity 105 member A | 2 | 2 | ||||||||
MIRT543005 | CRK | CRK proto-oncogene, adaptor protein | 2 | 2 | ||||||||
MIRT543814 | SNX10 | sorting nexin 10 | 2 | 2 | ||||||||
MIRT549303 | ARID5B | AT-rich interaction domain 5B | 2 | 2 | ||||||||
MIRT549407 | ADIPOR2 | adiponectin receptor 2 | 2 | 4 | ||||||||
MIRT550547 | ARSK | arylsulfatase family member K | 2 | 2 | ||||||||
MIRT554319 | SH3GLB1 | SH3 domain containing GRB2 like, endophilin B1 | 2 | 2 | ||||||||
MIRT554515 | RUFY2 | RUN and FYVE domain containing 2 | 2 | 2 | ||||||||
MIRT559603 | AMOT | angiomotin | 2 | 2 | ||||||||
MIRT564844 | ZBED3 | zinc finger BED-type containing 3 | 2 | 2 | ||||||||
MIRT566125 | RAD23B | RAD23 homolog B, nucleotide excision repair protein | 2 | 2 | ||||||||
MIRT567484 | FOXK1 | forkhead box K1 | 2 | 2 | ||||||||
MIRT576521 | Txlna | taxilin alpha | 2 | 2 | ||||||||
MIRT633635 | CASC5 | kinetochore scaffold 1 | 2 | 2 | ||||||||
MIRT639325 | C9orf41 | carnosine N-methyltransferase 1 | 2 | 2 | ||||||||
MIRT643174 | MDM2 | MDM2 proto-oncogene | 2 | 2 | ||||||||
MIRT651214 | ZNF225 | zinc finger protein 225 | 2 | 2 | ||||||||
MIRT653039 | STRIP2 | striatin interacting protein 2 | 2 | 2 | ||||||||
MIRT653042 | STOX2 | storkhead box 2 | 2 | 2 | ||||||||
MIRT658769 | EIF4EBP2 | eukaryotic translation initiation factor 4E binding protein 2 | 2 | 2 | ||||||||
MIRT666728 | RALY | RALY heterogeneous nuclear ribonucleoprotein | 2 | 2 | ||||||||
MIRT681223 | DUSP19 | dual specificity phosphatase 19 | 2 | 2 | ||||||||
MIRT685562 | SRD5A3 | steroid 5 alpha-reductase 3 | 2 | 2 | ||||||||
MIRT687434 | NR3C1 | nuclear receptor subfamily 3 group C member 1 | 2 | 2 | ||||||||
MIRT688439 | DNAJC3 | DnaJ heat shock protein family (Hsp40) member C3 | 2 | 2 | ||||||||
MIRT692707 | MEAF6 | MYST/Esa1 associated factor 6 | 2 | 2 | ||||||||
MIRT700552 | PTBP1 | polypyrimidine tract binding protein 1 | 2 | 2 | ||||||||
MIRT704955 | CBX2 | chromobox 2 | 2 | 2 | ||||||||
MIRT714524 | ALKBH3 | alkB homolog 3, alpha-ketoglutaratedependent dioxygenase | 2 | 2 | ||||||||
MIRT716225 | DGKI | diacylglycerol kinase iota | 2 | 2 | ||||||||
MIRT717953 | MIA3 | MIA family member 3, ER export factor | 2 | 2 | ||||||||
MIRT719902 | SERP1 | stress associated endoplasmic reticulum protein 1 | 2 | 2 | ||||||||
MIRT732044 | BLVRB | biliverdin reductase B | 3 | 1 | ||||||||
MIRT733622 | SNX5 | sorting nexin 5 | 3 | 0 | ||||||||
MIRT737210 | CXCR4 | C-X-C motif chemokine receptor 4 | 2 | 0 |
miRNA-Drug Associations | |||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|